Faculty 2015–2016 Cycle 8

Washington, DC

The American Course on Drug Development and Regulatory Sciences (ACDRS) teaching faculty are science-driven and highly experienced international faculty members with a network of experts in pharmaceutical medicine, medical product development, and regulatory sciences.

Name	Affiliation	Location
Charles Albright, MD, PhD	Merck and Co., Inc.	New York, NY
Ramsey Baghdadi	Prevision Policy	Washington, DC
Robert Ball, MD, MPH, ScM	US Food and Drug Administration	Silver Spring, MD
Scott Berry, PhD	Berry Consultants	Austin, TX
Bruce S. Binkowitz, PhD	Merck and Co., Inc.	Rahway, NJ
Lauren Black, PhD	Charles River Laboratories	Baltimore, MD
Terrence Blaschke, MD	University of California, San Francisco	San Francisco, CA
Sir Alasdair Breckenridge, FRSE, FMedSci	former MHRA chairman	London, United Kingdom
Joseph Caminiti	H4B Catapult	Hamilton, NJ
Gregory Campbell, PhD	Consultant	Washington, DC
Louis R. Cantilena, MD, PhD	Medical Strategic Initiatives, LLC	Bethesda, MD
Tim Coté, MD, MPH	Coté Orphan Consulting	Washington, DC
Theodore Danoff, MD, PhD	Clarus Therapeutics	Philadelphia, PA
Patricia Evans, PhD	Independent Consultant	Los Altos, CA
David W. Feigal, Jr, MD, MPH	Arizona State University School of Law	San Francisco, CA
Leslie C. Floren, PharmD	University of California, San Francisco	San Francisco, CA
Joshua Galanter, MD	University of California, San Francisco	San Francisco, CA
Mark J. Goldberger, MD, MPH	Consultant	Washington, DC
Charles T. Gombar, PhD	Bill and Melinda Gates Foundation	Seattle, WA
Charles Grudzinskas, PhD	NDA Partners, LLC	Annapolis, MD
David Hermann, PharmD	Great Lakes Drug Development / Certara	Detroit, MI
Christopher Horvath, DVM, MS, DACVP	bluebird bio	Cambridge, MA
Florence Houn, MD, MPH, FACP	Consultant	Washington, DC
John Jenkins, MD	US Food and Drug Administration	Silver Spring, MD
Diane K. Jorkasky, MD, FACP	Complexa Inc.	Philadelphia, PA
Kenneth Kaitin, PhD	Tufts University	Boston, MA
Jack Kloeber, PhD	Kromite	Philadelphia, PA
Zili Li, MD, MPH	Bill and Melinda Gates Foundation	Seattle, WA
Christopher Lipinski, PhD	Melior Discover	Waterford, CT
Murray M. Lumpkin, MD, MSc	Bill and Melinda Gates Foundation	Seattle, WA
David Macarios, MBA	Lifecell Corporation	Bridgewater, NJ
Diane Mould, PhD	Projections Research	Phoenixville, PA
Bernard Munos, MBA	InnoThink Center for Research in Biomedical Innovation	Indianapolis, IN
Mark Noguchi, MBA	Genentech	South San Francisco, CA
Ralph O'Brien, PhD	Case Western Reserve University (retired)	Cleveland, OH
Mary Parks, MD	US Food and Drug Administration	Silver Spring, MD
Carl C. Peck, MD	University of California, San Francisco	San Luis Obispo, CA
Saileta Prabhu, PhD	Genentech	South San Francisco, CA
William Prucka	Eli Lilly & Company	Indianapolis, IN
Joseph Rappon, OD, MS, FAAO	Alcon	Atlanta, GA
Frank Rockhold, PhD	GlaxoSmithKline	Raleigh-Durham, NC
Malcolm Rowland, PhD, DSc	University of California, San Francisco	London, United Kingdom
Stephen J. Ruberg, PhD	Eli Lilly and Company	Indianapolis, IN
Hansjorg Sauer, MS, PhD, JD	Biotechnology Industry Organization	Washington, DC
David Savello, PhD	NDA Partners LLC	Palo Alto, CA
Robert Seltzer, MBA	Care Capital	Princeton, NJ
Vikram Sinha, PhD	US Food and Drug Administration	Silver Spring, MD
Zachary Skrivanek	Eli Lilly and Company	Indianapolis, IN
Brian Smith, PhD	Novartis	Boston, MA/td>
Dominic G. Spinella, PhD	Amgen	Thousand Oaks, CA
S. Aubrey Stoch, MD	Merck and Co., Inc.	Rahway, NY
Norman Stockbridge, MD	US Food and Drug Administration	Silver Spring, MD
Karthik Venkatakrishnan, PhD FCP	Takeda	Deerfield, IL
Paolo Vicini, PhD	MedImmune	Cambridge, UK
Kristina Vlaovic, MPH	Halozyme	San Diego, CA
Russ Wada, PhD	Quantitative Solutions	Menlo Park, CA
Yaning Wang, PhD	US Food and Drug Administration	Silver Spring, MD
John Warren, JD	McDermott Will & Emery LLP	Washington, DC

Faculty in other years

See Faculty.